Sign in
4

Changes in Ownership

Tarsus Pharmaceuticals, Inc. Filed Acc 0001788542-23-000004

Chief Commercial Officer sold 1,078 shares at an average $12.55 ($13,531)

From the SEC's structured data for this filing

Trades in this filing

Mottiwala Aziz · Chief Commercial Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2023-03-21 Sale : show line 1 in the form −349 $12.89 $4,499 53,558 D
2023-03-22 Sale : show line 2 in the form −357 $12.64 $4,512 53,201 D
2023-03-23 Sale : show line 3 in the form −372 $12.15 $4,520 52,829 D
Open-market sales · 1,078 sh · avg $12.55 · $13,531
Loading xslF345X04/wf-form4_167961515955541.xml…